Table 2.
A) Question | First author, y | Study design | Screening /Diagnostic test assessed | N. patients | Level of evidence |
---|---|---|---|---|---|
2.1 a 2.2. b |
Ali, 1996 | Case–control | VFSS and manometry | 12 | III |
2.1 a | Bird, 1994 | Cross-sectional | Clinical examination | 16 | IV |
2.1 a | Hartelius, 1994 | Cross-sectional | Questionnaire | 258 | II |
2.1 a | Monteiro, 2014 | Case–control | Spirometry and VFSS | 30 | IV |
2.1 b | Buhmann, 2019 | Case–control | FEES | 118 | IV |
2.1 b | Claus, 2020 | Case–control | FEES | 200 | III |
2.1 b | Lam, 2007 | Cross-sectional | Questionnaire, WST, and VFSS | 45 | I |
2.1 b | Loureio, 2013 | Case–control | Questionnaire | 174 | IV |
2.1 b | Pflug, 2018 | Case–control | FEES | 122 | I |
2.1 b | Potulska, 2003 | Case–control | Electromyography and esophageal scintigraphy | 18 | IV |
2.1 b 2.2 b |
Rodrigues, 2011 | Cross-sectional | FEES | 28 | IV |
2.1 b | Sampaio, 2014 | Cross-sectional | FEES and voice recording | 19 | III |
2.1 b | Troche, 2016 | Cross-sectional | Voluntary and reflex cough and cough airflow (PEFR) | 64 | IV |
2.1 c | Belo, 2014 | Case–control | WST | 10 | IV |
2.1 c | Buhmann, 2019 | Case–control | Questionnaire | 119 | IV |
2.1 c | Kalf, 2011 | Cross-sectional | Questionnaire | 178 | IV |
2.1 c | Manor, 2007 | Cross-sectional | Questionnaire | 57 | III |
2.1 c | Minagi, 2018 | Case–control | WST, tongue pressure measurement | 30 | IV |
2.1 c | Simons, 2014 | Cross-sectional | Questionnaire | 82 | IV |
2.1 c | Singer, 1992 | Case–control | Questionnaire | 48 | IV |
2.1 c | Vogel, 2017 | Cross-sectional | Questionnaire | 60 | III |
2.1 c | Volontè, 2002 | Cross-sectional | Questionnaire | 65 | IV |
2.2 a | Hegland, 2014 | Case–control | Reflex cough testing | 22 | IV |
2.2 a | Kanna, 2014 | Case–control | WTS | 100 | IV |
2.2 a | Mari, 1997 | Cross-sectional | Questionnaire | 27 | II |
2.2 a | Miller, 2009 | Cross-sectional | WST | 137 | III |
2.2 a | Miyazaki, 2002 | Cross-sectional | WST | 24 | II |
2.2 a | Monte, 2005 | Cross-sectional | VFSS | 27 | IV |
2.2 a | Pitts, 2010 | Cross-sectional | PEFR and VFSS | 58 | III |
2.2 a | Pitts, 2018 | Cross-sectional | Tongue pressure measurement | 28 | IV |
2.2 a | Silverman, 2016 | Cross-sectional | PEFR | 68 | IV |
2.2 a | Troche, 2014 | Cross-sectional | Reflex cough testing and VFSS | 20 | IV |
2.2 b | Alfonsi, 2007 | Case–control | EKSS | 28 | IV |
2.2 b | Argolo, 2015a | Cross-sectional | VFSS | 69 | IV |
2.2 b | Argolo, 2015b | Cross-sectional | VFSS | 71 | IV |
2.2 b | Bassotti, 1998 | Case–control | Manometry | 18 | IV |
2.2 b | Castell, 2001 | Cross-sectional | Manometry | 16 | IV |
2.2 b | Cosentino, 2020 | Cross-sectional | Electrophysiological assessment of swallowing | 19 | IV |
2.2 b | Ding, 2018 | Cross-sectional | VFSS | 116 | III |
2.2 b | Ellerston, 2016 | Case–control | VFSS | 34 | IV |
2.2 b | Ertekin, 2002 | Case–control | Surface electromyography | 58 | III |
2.2 b | Fuh, 1997 | Cross-sectional | VFSS | 19 | IV |
2.2 b | Gaeckle, 2019 | Cross-sectional | VFSS | 89 | IV |
2.2 b | Hammer, 2013 | Cross-sectional | FEES | 18 | IV |
2.2 b | Johnston, 1997 | Case–control | VFSS and manometry | 7 | IV |
2.2 b | Jones, 2016 | Cross-sectional | VFSS | 26 | IV |
2.2 b | Jones, 2018 | Case–control | HRM | 31 | III |
2.2 b | Kim, 2020 | Cross-sectional | surface electromyography | 14 | IV |
2.2 b | Lee, 2015 | Case–control | VFSS | 29 | IV |
2.2 b | Lee, 2019 | Case–control | VFSS | 23 | IV |
2.2 b | Moreau, 2015 | Cross-sectional | VFSS | 70 | I |
2.2 b | Nagaya, 1998 | Case–control | VFSS | 16 | IV |
2.2 b | Schiffer, 2019 | Case–control | VFSS | 68 | IV |
2.2 b | Stroudley, 1991 | Cross-sectional | VFSS | 24 | III |
2.2 b | Su, 2017 | Cross-sectional | HRM | 33 | IV |
2.2 b | Suttrup, 2017 | Cross-sectional | HRM and FEES | 65 | IV |
2.2 b | Taira, 2020 | Cross-sectional | HRM | 51 | IV |
2.2 b | Tomita, 2018 | Case–control | VFSS | 184 | II |
2.2 b | Wakasugi, 2017 | Cross-sectional | VFSS | 201 | IV |
2.2 b | Wang, 2017 | Cross-sectional | EKSS | 42 | IV |
2.2 b | Ws Coriolano, 2012 | Cross-sectional | Surface electromyography | 15 | IV |
B) Question | First author, y | Study design | Outcome measure | N. patients | Level of evidence |
---|---|---|---|---|---|
2.3 a 2.4 a |
Akbar, 2015 | Retrospective | Incidence of aspiration pneumonia; survival | 5,665,710 | I |
2.3 a | Carneiro, 2014 | Prospective | Impact of dysphagia on QoL | 62 | IV |
2.3 a 2.4 a |
Cilia, 2015 | Retrospective | Survival, confinement to wheelchair or bed, fracture, PEG placement | 401 | II |
2.3 a | Han, 2011 | Prospective | Depression related to dysphagia | 127 | IV |
2.3 a 2.3 b |
Leow, 2010 | Prospective | Impact of dysphagia on QoL | 32 | III |
2.3 a 2.4 a |
Lorefält, 2006 | Prospective | Impact of dysphagia on QoL/Severity of dysphagia | 26 | IV |
2.3 a 2.3 b |
Manor, 2009 | Prospective | Mood changes related to dysphagia | 69 | II |
2.3 a | Miller, 2006 | Retrospective | Impact of dysphagia on QoL | 137 | III |
2.3 a | Plowman-Prine, 2009 | Prospective | Impact of dysphagia on QoL | 36 | III |
2.3 a | Silbergleit, 2012 | Prospective | Impact of dysphagia on emotional changes | 14 | IV |
2.3 a 2.3 b |
Storch, 2013 | Prospective | Impact of dysphagia on QoL | 100 | IV |
2.3 a 2.3 b |
Van Hooren, 2016 | Prospective | Impact of dysphagia on emotional changes | 100 | IV |
2.4 a | Auyeung, 2012 | Retrospective | Survival | 171 | II |
2.4 a | Fabbri, 2019 | Retrospective and Prospective Cross-sectional | Survival, institutionalization | 50 | I |
2.4 a | Hussain, 2018 | Retrospective | Survival | 51 | III |
2.4 a | Lo, 2009 | Retrospective | Survival | 573 | II |
2.4 a | Malmgren, 2011 | Retrospective | Survival | 191 | III |
2.4 a | Müller, 2001 | Retrospective | Survival | 17 | II |
2.4 a | Robbins, 2008 | Prospective | Pneumonia | 255 | I |
2.4 a | Barichella, 2013 | Prospective | Nutritional status | 208 | I |
2.4 a | Cereda, 2014 | Retrospective | Non-motor symptoms | 6462 | IV |
2.4 a | Goh, 2016 | Retrospective | Pneumonia and choking | 194 | II |
2.4 a | Lee, 2016 | Prospective | Pneumonia | 66 | IV |
2.4 a | Miller, 2009 | Prospective | Impact of dysphagia on PD | 137 | III |
Studies were classified according to various descriptors (e.g., study design, presence or not of a reference standard diagnostic test, sampling method, sample size, blinding, presence of clearly stated inclusion and exclusion criteria) according to the Classification of Evidence Schemes of the Clinical Practice Guideline Process Manual of the American Academy of Neurology 17. Each study was graded according to its risk of bias from Class I to Class IV (with I corresponding to the highest quality and IV to the lowest quality)
EKSS Electro-Kinesiologic Swallowing Study; FEES Fiberoptic endoscopic evaluation of swallowing; HRM High-resolution manometry; PEG Percutaneous Endoscopic Gastrostomy; PEFR Peak expiratory airflow rate; VFSS Videofluoroscopic study of swallowing; WST Water swallow test